107 related articles for article (PubMed ID: 136966)
1. Metabolic consequences of drug-induced inhibition of the pentose phosphate pathway in neuroblastoma and glioma cells.
Kolbe H; Keller K; Lange K; Herken H
Biochem Biophys Res Commun; 1976 Nov; 73(2):378-82. PubMed ID: 136966
[No Abstract] [Full Text] [Related]
2. Metabolism via the pentose phosphate pathway in rat pheochromocytoma PC12 cells: effects of nerve growth factor and 6-aminonicotinamide.
Davis LH; Kauffman FC
Neurochem Res; 1987 Jun; 12(6):521-7. PubMed ID: 2955240
[TBL] [Abstract][Full Text] [Related]
3. Effect of 6-aminonicotinamide on pentose cycle activity in isolated hepatocytes.
Carmona A; Freedland RA
Int J Biochem; 1990; 22(6):595-9. PubMed ID: 2143150
[TBL] [Abstract][Full Text] [Related]
4. Studies of carbohydrate metabolism in rat kidney after pharmacological blockade of the pentose phosphate pathway.
Kolbe H; Keller K; Lange K; Herken H
Naunyn Schmiedebergs Arch Pharmakol; 1971; 271(1):93-102. PubMed ID: 4256398
[No Abstract] [Full Text] [Related]
5. The effect of 6-aminonicotinamide blockade of the pentose phosphate pathway on catecholamines in the rat adrenal medulla, superior cervical ganglion, hypothalamus and synaptosome fractions.
Jansson SE; Gripenberg J; Härkönen M
Acta Physiol Scand; 1977 Apr; 99(4):467-75. PubMed ID: 140588
[TBL] [Abstract][Full Text] [Related]
6. The role of the pentose phosphate shunt in thyrotropin-induced thyroid hormone secretion: in vivo and vitro studies with 6-aminonicotinamide in mouse thyroids.
Hashizume K; Onaya T; Sato A
Endocrinology; 1975 Oct; 97(4):962-8. PubMed ID: 172320
[TBL] [Abstract][Full Text] [Related]
7. The rate of utilization of glucose via hexosemonophosphate shunt in brain.
Gaitonde MK; Evison E; Evans GM
J Neurochem; 1983 Nov; 41(5):1253-60. PubMed ID: 6619864
[TBL] [Abstract][Full Text] [Related]
8. Direct in vivo quantitation of the pentose phosphate pathway in brain.
Hakim AM; Moss G
Trans N Y Acad Sci; 1972 Jun; 34(6):473-90. PubMed ID: 4504581
[No Abstract] [Full Text] [Related]
9. Decreased glycolytic flux rate in the isolated perfused rat brain after pretreatment with 6-aminonicotinamide.
Krieglstein J; Stock R
Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):323-7. PubMed ID: 127127
[TBL] [Abstract][Full Text] [Related]
10. The effect of 6-aminonicotinamide on the levels of brain amino acids and glucose, and their labeling with 14C after injection of [U-14C] glucose.
Gaitonde MK; Lewis LP; Evans G; Clapp A
Neurochem Res; 1981 Oct; 6(10):1159-67. PubMed ID: 6121299
[TBL] [Abstract][Full Text] [Related]
11. Quantitative measurement of the L-type pentose phosphate cycle with [2-14C]glucose and [5-14C]glucose in isolated hepatocytes.
Longenecker JP; Williams JF
Biochem J; 1980 Jun; 188(3):859-65. PubMed ID: 7470039
[TBL] [Abstract][Full Text] [Related]
12. Glycolysis and glycogen metabolism after inhibition of hexose monophosphate pathway in C6-GLIAL cells.
Keller K; Kolbe H; Herken H; Lange K
Naunyn Schmiedebergs Arch Pharmacol; 1976 Aug; 294(2):213-5. PubMed ID: 138094
[TBL] [Abstract][Full Text] [Related]
13. The effect of inhibition of hexosemonophosphate shunt on the metabolism of glucose and function in rat brain in vivo.
Gaitonde MK; Evans GM
Neurochem Res; 1982 Sep; 7(9):1163-79. PubMed ID: 6217428
[TBL] [Abstract][Full Text] [Related]
14. Blocking of pentose phosphate pathway in the brain of rats by 6-aminonicotinamide.
Herken H; Lange K
Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(3):496-9. PubMed ID: 4389238
[No Abstract] [Full Text] [Related]
15. Alternative pathways of glucose utilization in brain; changes in the pattern of glucose utilization in brain resulting from treatment of rats with 6-aminonicotinamide.
Hothersall JS; Zubairu S; McLean P; Greenbaum AL
J Neurochem; 1981 Dec; 37(6):1484-96. PubMed ID: 6460850
[TBL] [Abstract][Full Text] [Related]
16. Interrelationship and control of glucose metabolism and lipogenesis in isolated fat-cells. Control of pentose phosphate-cycle activity by cellular requirement for reduced nicotinamide adenine dinucleotide phosphate.
Kather H; Rivera M; Brand K
Biochem J; 1972 Aug; 128(5):1097-102. PubMed ID: 4404963
[TBL] [Abstract][Full Text] [Related]
17. Spastic paresis after 6-aminonicotinamide: metabolic disorders in the spinal cord and electromyographically recorded changes in the hind limbs of rats.
Herken H; Meyer-Estorf G; Halbhübner K; Loos D
Naunyn Schmiedebergs Arch Pharmacol; 1976 Jun; 293(3):245-55. PubMed ID: 134291
[TBL] [Abstract][Full Text] [Related]
18. The effect of hypoxia on the pentose phosphate pathway in brain.
Hakim AM; Moss G; Gollomp SM
J Neurochem; 1976 Apr; 26(4):683-8. PubMed ID: 965959
[No Abstract] [Full Text] [Related]
19. Pentose phosphate shunt and gastric acid secretion in the rat.
Sernka TJ; Harris JB
Am J Physiol; 1972 Jan; 222(1):25-32. PubMed ID: 4400690
[No Abstract] [Full Text] [Related]
20. Metabolism of glucose into glutamate via the hexose monophosphate shunt and its inhibition by 6-aminonicotinamide in rat brain in vivo.
Gaitonde MK; Jones J; Evans G
Proc R Soc Lond B Biol Sci; 1987 Jun; 231(1262):71-90. PubMed ID: 2888118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
